Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03505320
Title A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (IMAB362) in Participants With Claudin (CLDN) 18.2 Positive, Metastatic or Advanced Unresectable Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma and Locoregional Gastric or GEJ Adenocarcinoma (ILUSTRO)
Acronym ILUSTRO
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute WITHDRAWN Los Angeles California 90025 United States Details
UCLA Medical Center WITHDRAWN Santa Monica California 90404 United States Details
Georgetown Univ Hospital WITHDRAWN Washington District of Columbia 20007 United States Details
University of Chicago RECRUITING Chicago Illinois 60637 United States Details
Indiana University Cancer Center WITHDRAWN Indianapolis Indiana 46077 United States Details
Mass General / North Shore Can RECRUITING Boston Massachusetts 02114 United States Details
Karmanos Cancer Institute WITHDRAWN Detroit Michigan 48201 United States Details
Memorial Sloan Kettering Cancer Center WITHDRAWN New York New York 10065 United States Details
Weill Cornell Medical College COMPLETED New York New York 10065 United States Details
Sanford Cancer Center WITHDRAWN Sioux Falls South Dakota 57104 United States Details
Virginia Cancer Specialists WITHDRAWN Fairfax Virginia 22031 United States Details
Site FR33003 RECRUITING Pessac Nouvelle-Aquitaine 33604 France Details
Site FR33002 RECRUITING Poitiers Nouvelle-Aquitaine 86021 France Details
Site FR33001 RECRUITING Brest France Details
Site FR33004 RECRUITING Paris 75015 France Details
Site IT39005 RECRUITING Milano Italy Details
Site IT39002 RECRUITING Napoli Italy Details
Site IT39004 SUSPENDED Padova Italy Details
Site IT39003 RECRUITING Pisa Italy Details
Site JP81001 RECRUITING Chiba Japan Details
Site JP81002 RECRUITING Tokyo Japan Details
Site JP81003 RECRUITING Tokyo Japan Details
Site KR82002 SUSPENDED Seongnam-si Korea, Republic of Details
Site KR82001 SUSPENDED Seoul Korea, Republic of Details
Site TW88601 SUSPENDED Taichung Taiwan Details
Site TW88602 SUSPENDED Tainan 70403 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field